Recent Advances in Functionalized Nanoparticles in Cancer Theranostics

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer theranostics integrates diagnosis and therapy for personalized treatment, aiming to improve patient outcomes by reducing treatment delays.
• Nanoparticle functionalization enhances efficiency, specificity, and stability, revolutionizing cancer detection and therapy.
• Combining various treatment modalities (e.g., MRI-guided therapies, immunotherapy, photothermal therapy) offers a superior platform for cancer control.

Purpose of the Study:

• To review recent advancements in cancer theranostics utilizing functionalized nanoparticles.
• To explore the potential of functionalized nanoparticles in improving cancer diagnosis and therapy.
• To identify future challenges and perspectives in nanoparticle-based cancer theranostics.

Main Methods:

• Review of recent scientific literature on functionalized nanoparticles in cancer theranostics.
• Analysis of the impact of nanoparticle functionalization on theranostic performance.
• Synthesis of information on combined therapeutic modalities enabled by nanoparticles.

Main Results:

• Functionalized nanoparticles significantly improve the efficiency, specificity, and stability of cancer theranostic systems.
• Nanoparticle-based theranostics offer a versatile platform for integrating multiple cancer treatment strategies.
• Recent advances highlight the revolutionary potential of these agents in cancer care.

Conclusions:

• Functionalized nanoparticles are pivotal in advancing cancer theranostics, offering improved diagnostic and therapeutic capabilities.
• The integration of diverse treatment modalities through nanoparticles promises enhanced cancer control.
• Continued research into nanoparticle-based cancer theranostics is crucial for addressing future challenges and realizing its full potential.